Lumipulse® pTau-217/Beta Amyloid 42 Ratio, Plasma-994

Test info

  
Lumipulse® pTau-217/Beta Amyloid 42 Ratio, Plasma
  
994
  
LAB994
  
MSO
  
217/42
patu217/42 ratio
ptau217/Abeta42 ratio
Lumipulse®
  

The Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio is indicated for adult patients, aged 50 years and older, presenting at a specialized care setting with signs and symptoms of cognitive decline.

Specimen

  
EDTA plasma
  
  
1 mL
  
0.75 mL
  

Immediately following collection, mix sample thoroughly by gentle inverting 8 - 10 times, to prevent clotting

  
  1. Spin within 2 hours of collection
  2. Immediately transfer the plasma into a Screw-cap polypropylene frozen transport vial/tube - 4mL (LabCorp).
  3. Freeze 
  

Frozen (preferred) - 1 month

Refrigerated - 1 day

Ambient - 3 hours

  
  • Serum specimen
  • Hemolyzed, lipemic, or heat treated specimen
  • Gross bacterial contamination

Performance

  
LabCorp (505809); R-NX
  
5 - 7 days
  

Fujirebio Lumipulse chemiluminescent enzyme immunoassay (CLEIA)

Clinical and Interpretive info

  

See report

Billing

  
83520 x2

Tracking

  
11/14/2025
  
11/14/2025